Announcement
24 Oct 2019
In October 2019, the European Investment Bank (EIB) signed a loan agreement with Mabion S.A. to support the company's late and early-state biosimilar drug development as well as scale-up manufacturing activities in Poland.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
24 Oct 2019
Revocation date:
No revocation date
Updated: 24 Oct 2019
State loan
In force
On 24 October 2019, the European Investment Bank (EIB) signed a loan agreement with Mabion S.A. having a total value of EUR 30 million (approx. USD 33.3 million). The loan ...
Sign in to see more
Threads
See all
This state act is not part of any Thread yet.